1. Home
  2. QRVO vs ICLR Comparison

QRVO vs ICLR Comparison

Compare QRVO & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Qorvo Inc.

QRVO

Qorvo Inc.

HOLD

Current Price

$96.41

Market Cap

7.9B

Sector

Technology

ML Signal

HOLD

Logo ICON plc

ICLR

ICON plc

N/A

Current Price

$161.09

Market Cap

9.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
QRVO
ICLR
Founded
1957
1990
Country
United States
Ireland
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Commercial Physical & Biological Resarch
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.9B
9.3B
IPO Year
2014
2001

Fundamental Metrics

Financial Performance
Metric
QRVO
ICLR
Price
$96.41
$161.09
Analyst Decision
Hold
Buy
Analyst Count
13
13
Target Price
$90.64
$178.62
AVG Volume (30 Days)
948.7K
527.9K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
524.14
N/A
EPS
3.62
N/A
Revenue
$3,678,517,000.00
N/A
Revenue This Year
$0.81
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$26.54
$12.91
Revenue Growth
N/A
N/A
52 Week Low
$75.43
$66.57
52 Week High
$109.49
$203.91

Technical Indicators

Market Signals
Indicator
QRVO
ICLR
Relative Strength Index (RSI) 55.00 42.40
Support Level $92.89 $150.86
Resistance Level $99.08 $183.11
Average True Range (ATR) 2.46 6.54
MACD -0.26 -0.91
Stochastic Oscillator 59.71 6.75

Price Performance

Historical Comparison
QRVO
ICLR

About QRVO Qorvo Inc.

Qorvo represents the combined entity of RF Micro Devices and TriQuint Semiconductor, which merged in January 2015. The company specializes in radio frequency filters, power amplifiers, and front-end modules used in many of the world's most advanced smartphones. Qorvo also has a suite of products sold into a variety of non-smartphone end markets, such as wireless base stations, cable TV and networking equipment, and infrastructure and military applications.

About ICLR ICON plc

Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.

Share on Social Networks: